Two Onc Docs cover image

Metastatic Kidney Cancer x Uromigos 2025 UPDATES (Part 2)

Two Onc Docs

00:00

Navigating Treatment Breaks in Immunotherapy for Kidney Cancer

This chapter explores the intricacies of treatment breaks for patients on adjuvant immunotherapy for metastatic kidney cancer. It highlights a pivotal UK study on patient survival and well-being, advocating for a balanced approach to allow patients necessary respite from treatment.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app